Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.

Galbally M, Gentile S, Lewis AJ.

CNS Drugs. 2012 Oct 1;26(10):813-22. doi: 10.2165/11630310-000000000-00000. Review.

PMID:
22950489
2.
3.

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.

Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

BMJ. 2014 Jan 14;348:f6932. doi: 10.1136/bmj.f6932. Review.

4.

Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.

Ornoy A, Koren G.

Semin Fetal Neonatal Med. 2014 Jun;19(3):188-94. doi: 10.1016/j.siny.2013.11.007. Epub 2013 Dec 8. Review.

PMID:
24321501
5.

Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review.

't Jong GW, Einarson T, Koren G, Einarson A.

Reprod Toxicol. 2012 Nov;34(3):293-7. doi: 10.1016/j.reprotox.2012.04.015. Epub 2012 May 5. Review.

PMID:
22564982
6.

The effect of perinatal exposures on the infant: antidepressants and depression.

Hanley GE, Oberlander TF.

Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):37-48. doi: 10.1016/j.bpobgyn.2013.09.001. Epub 2013 Sep 18. Review.

PMID:
24100223
7.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
8.

Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Byatt N, Deligiannidis KM, Freeman MP.

Acta Psychiatr Scand. 2013 Feb;127(2):94-114. doi: 10.1111/acps.12042. Epub 2012 Dec 14. Review.

9.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
10.

To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects.

Austin MP.

Psychol Med. 2006 Dec;36(12):1663-70. Epub 2006 Jul 25. Review.

PMID:
16863595
11.

Fetal and neonatal effects of maternal drug treatment for depression.

Belik J.

Semin Perinatol. 2008 Oct;32(5):350-4. doi: 10.1053/j.semperi.2008.08.001. Review.

PMID:
18929158
12.

Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Autism Res. 2013 Jun;6(3):149-68. doi: 10.1002/aur.1288. Epub 2013 Mar 14. Review.

PMID:
23495208
13.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
14.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258
15.

Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Gur TL, Kim DR, Epperson CN.

Psychopharmacology (Berl). 2013 Jun;227(4):567-82. doi: 10.1007/s00213-013-3115-8. Epub 2013 May 17. Review.

16.

Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn.

Van Marter LJ, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA.

Pediatrics. 2013 Jan;131(1):79-87. doi: 10.1542/peds.2012-0496. Epub 2012 Dec 3. Review.

17.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
18.

Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

Klinger G, Merlob P.

Isr J Psychiatry Relat Sci. 2008;45(2):107-13. Review.

19.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
20.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382

Supplemental Content

Support Center